TABLE 3.
Treatments and complications
| Characteristics | All patients(N = 77) | Syncope(N = 37) | No syncope(N = 40) | P‐value |
|---|---|---|---|---|
| Treatments | ||||
| Admit to intensive care unit—No. (%) | 19 (25) | 5 (14) | 14 (35) | .03 |
| Invasive mechanical ventilation—No. (%) | 18 (23) | 5 (14) | 13 (33) | .06 |
| Bi‐level positive airway pressure—No. (%) | 16 (21) | 8 (22) | 8 (20) | 1.00 |
| Nonrebreather mask—No. (%) | 36 (47) | 18 (49) | 18 (45) | .82 |
| High‐flow nasal cannula—No. (%) | 13 (17) | 7 (19) | 6 (15) | .74 |
| Hydroxychloroquine—No. (%) | 67 (87) | 30 (81) | 37 (93) | .20 |
| Azithromycin—No. (%) | 46 (60) | 19 (51) | 27 (68) | .18 |
| Immunomodulators—No. (%) | ||||
| Sirolumab—No. (%) | 2 (3) | 1 (3) | 1 (3) | 1.00 |
| Tocilizumab—No. (%) | 3 (4) | 2 (5) | 1 (3) | .60 |
| Remdesivir—No. (%) | 3 (4) | 0 | 3 (7.5) | .24 |
| Glucocorticoids—No. (%) | 23 (30) | 9 (24) | 14 (35) | .3 |
| Therapeutic anticoagulation—No. (%) | 38 (49) | 19 (51) | 19 (48) | .82 |
| Complications | ||||
| Myocardial injury—No. (%) | 35 (44) | 14 (38) | 21 (53) | .25 |
| Acute MI | 4 (5) | 4 (11) | 0 (0) | .05 |
| Acute kidney injury—No. (%) | 24 (32) | 11 (30) | 13 (33) | 1.00 |
| Acute kidney injury requiring renal replacement therapy—No. (%) | 7 (9) | 1 (3) | 6 (15) | .11 |
| Shock, requiring pressors—No. (%) | 16 (21) | 4 (11) | 12 (30) | .08 |
| Acute respiratory distress syndrome—No. (%) | 34 (44) | 15 (41) | 19 (48) | .65 |
| Ischemic stroke—No. (%) | 1 (2) | 1 (3) | 0 (0) | .50 |
| Pulmonary embolism—No. (%) | 5 (7) | 2 (6) | 3 (8) | 1.00 |
| Deep vein thrombosis—No. (%) | 3 (4) | 1 (3) | 2 (5) | 1.00 |
| Death—No. (%) (N = 60) | 14 (23) | 5 (18) | 9 (28) | .38 |
| Palliative care—No. (%) | 7 (50) | 3 (60) | 4 (44) | 1.00 |
| ICU length of stay, mean ± SD | 3.05 ± 5.5 | 1.4 ± 3.6 | 4.1 ± 6.2 | .09 |
| Hospital length of stay, median (IQR)—No. (%) | 10 (6‐15) | 10 (7‐17) | 10 (6‐15) | .8 |
All values are expressed as median (IQR), unless otherwise specified.
P‐values < 0.05 were bolded to highlight significance.